Clinical Trials · NCT01163084
Leuprolide Acetate or Goserelin Acetate With or Without Vismodegib Followed by Surgery in Treating Patients With Locally Advanced Prostate Cancer
- Phase
- Phase 1/Phase 2
- Recruitment status
- Terminated
- Sponsor
- National Cancer Institute (NCI)
- Enrollment
- 10
- Start date
- Jul 2010
- Locations
- 5 sites, United States
- Primary endpoint
- Proportion of Patients With =< 5% Tumor Involvement